December 23, 2014
A Texas federal judge on Tuesday found Actavis PLC jumped the gun by asserting Allergan Inc's patents for a dry-eye medication were invalid or unenforceable before Actavis's application for a generic version of the drug was accepted by the Food and Drug Administration.